Anna Wong focuses her practice on intellectual property and regulatory litigation in the life sciences sector.  She represents clients in federal court, arbitral, and post-grant proceedings, and has worked on matters spanning small molecule therapeutics, antibody-drug conjugates, CAR-T therapies, LNP delivery systems, and genetic sequencing technologies. She also regularly works on drug pricing and innovation policy issues.  

Prior to joining the firm, Ms. Wong worked as a pharmaceutical policy researcher and served as a legal fellow at an international health organization. 

Insights & News

Credentials

  • Education

    • JD, University of Toronto, Faculty of Law, 2023

      Senior Board Editor, UofT Faculty of Law Review

      Massey College Junior Fellow

      International Human Rights Program Fellow

    • BSc, Molecular Genetics & Microbiology/International Relations, University of Toronto, 2020

      Honors with High Distinction
  • Admissions

    • Massachusetts

  • Languages

    • French

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.